Artikkel ×
58 results
  1. Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study

    Cunningham, Evan B, Hajarizadeh, Behzad, Dalgard, Olav, Amin, Janaki, Hellard, Margaret, Foster, Graham R, Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert, Swan, Tracy, Marks, Philippa S, Quiene, Sophie, Applegate, Tanya L, Weltman, Martin, Shaw, David, Dunlop, Adrian, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Thurnheer, Maria Christine, Dore, Gregory J, Grebely, Jason, Shaw, Ineke, Siriragavan, Sharmila, Horschik, Tina, Sharma, Shawn, Eevers, Anita, Andreassen, Jessica, Melkeraaen, Ingunn, Widder, Nicole, Lesneuck, Kristof, Kotsoros, Barbara, Hazelwood, Susan, Holland, Rohan, Axten, David, Von Bibra, Sally, Powis, Jeff, Mason, Kate, Ryder, Stephen, Jack, Kate, Scheidegger, Claude, Huber, Christine, Ferguson, Catherine, Staehelin, Cornelia, Lacalamita, Melanie, Fragomeli, Vincenzo, Sevehon, Alison ()
  2. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

    Grebely, Jason, Bruneau, Julie, Lazarus, Jeffrey, Dalgard, Olav, Bruggmann, Philip, Treloar, Carla, Hickman, Matthew, Hellard, Margaret, Roberts, Teri, Crooks, Levinia, Midgard, Håvard, Larney, Sarah, Degenhardt, Louisa, Alho, Hannu, Byrne, Jude, Dillon, John F, Feld, Jordan J, Foster, Graham, Goldberg, David E, Lloyd, Andrew R, Reimer, Jens, Robaeys, Geert, Torrens, Marta, Wright, Nat, Maremmani, Icro, Norton, Brianna L, Litwin, Alain H, Dore, Gregory J ()